Peer Review History
| Original SubmissionSeptember 15, 2023 |
|---|
|
PONE-D-23-29703Suppression of the alpha, delta, and omicron variants of SARS-Cov-2 in Taiwan.PLOS ONE Dear Dr. Tsou, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Thank you for submitting your important manuscript to PLOS ONE.I think the comments raised by the 2 independent reviewers seem minor.Please submit your revised version soon. Please submit your revised manuscript by Nov 30 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Etsuro Ito, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following in your Competing Interests section: "All authors declare no conflicts of interest, including employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications and travel grants". Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now This information should be included in your cover letter; we will change the online submission form on your behalf. 3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. 4. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ 5. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 6. We note that Figures 5 and 7 in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright. We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission: 1. You may seek permission from the original copyright holder of Figures 5 and 7 to publish the content specifically under the CC BY 4.0 license. We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text: “I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.” Please upload the completed Content Permission Form or other proof of granted permissions as an ""Other"" file with your submission. In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].” 2. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only. The following resources for replacing copyrighted map figures may be helpful: USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/ The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/ Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/ Landsat: http://landsat.visibleearth.nasa.gov/ USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/# Natural Earth (public domain): http://www.naturalearthdata.com/ 7. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: PLOS ONE PONE-D-23-29703 - [EMID:d1fc004c3e3e78de] Title: Suppression of the alpha, delta, and omicron variants of SARS-Cov-2 in Taiwan. General Comments: This article shares Taiwan's experience in combating the Alpha and Delta virus strains, which have higher mortality rates despite the lack of a vaccine. In the face of the Omicron virus, which is highly contagious but has a relatively mild fatality rate, Taiwan has also gradually opened its borders and successfully conquered the Omicron epidemic. This article describes four key factors underlying Taiwan's success in controlling the spread of COVID-19: quick responses; effective control measures with new technologies and rolling knowledge updates; unity and cooperation among Taiwanese government agencies, private companies and organizations, and individual citizens; and Taiwanese self-discipline. I think these experiences are worth sharing with other countries. The topic of this article falls within the scope of this journal. I have the following suggestions. 1. Taiwan’s reality is different from many other countries, in part because it only borders the sea. Nonetheless, the timeliness of border management measures (earlier introduction of entry restrictions and health screening) may have contributed to Taiwan's relatively low number of cases. This article does not explore this as the early introduction of border controls is mentioned but its impact is not discussed further or compared with other countries. I suggest the author compare the epidemic outcomes-related performance of Taiwan and other island countries. Please discuss whether island countries can help prevent the epidemic. 2. This article presented four factors for controlling the spread of COVID-19 in Taiwan. Nevertheless, the importance of mandatory interventions (contact tracing, quarantine, border control) versus non-mandatory interventions (use of masks, social distancing) was not discussed. Individual self-discipline may have played a smaller role than mandatory restrictions that can be backed-up by legal legislation. I suggest the author mention this in the discussion section. Some modelling studies may be added in the discussion, for example: (1) The effect of preventing subclinical transmission on the containment of COVID-19: Mathematical modeling and experience in Taiwan. https://www.sciencedirect.com/science/article/pii/S1551714420301798 (2) Relative role of border restrictions, case finding and contact tracing in controlling SARS-CoV-2 in the presence of undetected transmission: a mathematical modelling study https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019421/ 3. A modelling analysis using Taiwan case data concluded that population-based interventions may have played a major role in Taiwan's initial elimination efforts and that case-based interventions alone were insufficient to control the epidemic. I suggest the authors add the findings in the discussion section. (1) Comparison of Estimated Effectiveness of Case-Based and Population-Based Interventions on COVID-19 Containment in Taiwan. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2778395 4. Several articles have discussed Taiwan’s experience and potential lessons in combating COVID-19, and this article does not add to what has been published. It would be important to cite and compare previous works on the Taiwanese experience, i.e., in order to support some of the results presented in the manuscript. For example, (1) Comparison of Estimated Effectiveness of Case-Based and Population-Based Interventions on COVID-19 Containment in Taiwan. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2778395 (2) Fighting COVID‐19 through government initiatives and collaborative governance: the Taiwan experience. Public Administration Review, 80(4), 665-670. (3) An American's perspective living through COVID-19 in Taiwan. Journal of the Formosan Medical Association, 119(12), 1884. 5. Contact tracing is considered an important strategy to curb the spread of COVID-19. While this is true, no relevant references are provided to support this confirmation. It would be interesting to discuss the transmissibility of COVID-19) to close contacts. For example, there is a report from Taiwan on the use of contact tracing and testing to assess COVID-19 transmission dynamics among the first 100 confirmed cases in the country. (1) Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset. JAMA internal medicine, 180(9), 1156-1163. 6. The findings underscore the need for accurate, comprehensive contact tracing and testing. However, they also stressed that simply identifying and isolating symptomatic patients may not be enough to interrupt transmission, and that social distancing measures will also be needed. A modeling study also suggests that isolating all at-risk cases through contact tracing can control the outbreak. (1) The effect of preventing subclinical transmission on the containment of COVID-19: Mathematical modeling and experience in Taiwan. https://www.sciencedirect.com/science/article/pii/S1551714420301798 Reviewer #2: I read the manuscript “Suppression of the alpha, delta, and omicron variants of SARS-Cov-2 in Taiwan.” and I thank the authors and the journal for the possibility of reviewing this manuscript. The authors describe Taiwan's responses to alpha, delta, and omicron variants. Taiwan has controlled its borders and implemented strict quarantine rules in the first two years of pandemic (2020 and 2021), keeping infection and deaths numbers low. Taiwan then gradually eased border measures in March 2023, when Taiwan faced a new variant of concern: Omicron. In this manuscript, four factors for controlling the spread of COVID-19 in Taiwan are presented. They are (1) Quick response; (2) Effective control measures and precise quarantine strategy; (3) Individual self-discipline; (4) Unity and cooperation. The paper provides valuable perspective on Taiwan's success in controlling the spread of COVID-19, especially in the face of alpha and delta variants. I think this article can be improved by addressing the following issues. It would be beneficial for the authors to broaden their horizons and consider other infectious diseases that may cause pandemics in the future. (1)The abstract should include some methods and results, not just the background and conclusion. (2)The methods section lacks some important details that readers need to evaluate the methods used. For example, the authors analyzed the time to border closure and conducted one-sample test to compare between Taiwan and Non-Taiwan countries prior to vaccine introduction. It’s unclear how the time to border closure was calculated. Please provide more details. (3)More information is needed about the data sources and how the time-varying reproduction number (Rt) was calculated, including the model used to estimate Rt and any assumptions made in the analysis. The authors are suggested to provide link to the data sources and the code used for calculating Rt in order to encourage reproducibility of their results. (4)Taiwan adopted a COVID-zero approach in the first two years of pandemic (2020 and 2021), keeping infection and deaths low. I wonder how the COVID-zero approach affects the economy or social health in Taiwan. (5)In the discussion section, please indicate some of the limitations of your study. Addressing these concerns would strengthen the paper's argument and provide a more comprehensive understanding of Taiwan's approach to controlling the spread of COVID-19. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Suppression of the Alpha, Delta, and Omicron variants of SARS-Cov-2 in Taiwan. PONE-D-23-29703R1 Dear Dr. Tsou, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Etsuro Ito, Ph.D. Academic Editor PLOS ONE |
| Formally Accepted |
|
PONE-D-23-29703R1 PLOS ONE Dear Dr. Tsou, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Etsuro Ito Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .